Advertisement

Pharmacotherapy of Joint and Soft Tissue Injections

  • Todd P. Stitik
  • Ajay Kumar
  • Jong H. Kim
  • Jiaxin J. Tran
  • Charles Lee
Chapter

Abstract

The most common medications used for office-based joint and soft tissue injection procedures include injectable corticosteroids and local anesthetics. In particular, the intra-articular administration of corticosteroids has been used for more than 50 years to help diagnose and/or treat various joint disorders [1]. Corticosteroids are also often injected into bursae, into tendon sheaths, at tendon insertion sites, and into muscular trigger points. Although corticosteroid injections (CSIs) may not cure the underlying disease process and can potentially worsen it, they can act rapidly and be extremely effective in relieving pain and inflammation [2]

Keywords

Carpal Tunnel Syndrome Triamcinolone Acetonide Tendon Sheath Adhesive Capsulitis Plantar Fasciitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Hollander JL. Prednisone and prednisolone: newest corticosteroids. Merck Rep 1955;64(4):3–7.PubMedGoogle Scholar
  2. 2.
    Siegmeth W, Krepelka M, Supper A. Intra-articular injections in arthrosis of the small and medium size joints. Wiener Medizinische Wochenschrift 1995;145(5):117–9.PubMedGoogle Scholar
  3. 3.
    Stefanich RJ. Intra-articular corticosteroids in treatment of osteoarthritis. Orthop Rev 1986;15:65–71.PubMedGoogle Scholar
  4. 4.
    Eymontt MJ, Gordon GV, Schumacher HR, Hansell JR. The effects on synovial permeability and synovial fluid leukocyte counts in symptomatic osteoarthritis after intraarticular corticosteroid administration. J Rheumatol 1982;9(2):198–203.PubMedGoogle Scholar
  5. 5.
    Goetzl EJ, Bianco NE, Alpert JS, Sledge, CB, Schur PH. Effects of intra-articular corticosteroids in vivo on synovial fluid variables in rheumatoid arthritis. Ann Rheum Dis 1974;33:62–6.PubMedCrossRefGoogle Scholar
  6. 6.
    Hunder GC, McDuffie FC. Effect of intra-articular hydrocortisone on complement in synovial fluid. J Lab Clin Med 1972;79:62–74.PubMedGoogle Scholar
  7. 7.
    Mazanec DJ. Pharmacology of corticosteroids in synovial joints. Phys Med Rehabil Clin North Am 1995;6:815–21.Google Scholar
  8. 8.
    Butler WT, Rossen RD. Effects of corticosteroids on immunity in man. J Clin Invest 1973;52:2629–40.PubMedCrossRefGoogle Scholar
  9. 9.
    Fauci AS, Dale DC, Balow JE. Glucocorticoid therapy: mechanisms of action and clinical considerations. Ann Intern Med 1976;84:304–15.PubMedGoogle Scholar
  10. 10.
    Saxon A, Stevens RH, Ramer SJ. Glucocorticoids administered in vivo inhibit human suppressor T lymphocyte function and diminish B lymphocyte responsiveness in vitro immunoglobulin synthesis. J Clin Invest 1977;60:922–30.CrossRefGoogle Scholar
  11. 11.
    Pelletier JP, McCollum R, DiBattista J, Loose LD, Cloutier JM, Martel-Pelletier J. Regulation of human normal and osteoarthritic chondrocyte interleukin-1 receptor by antirheumatic drugs. Arthritis Rheum 1993;36:1517–27.PubMedCrossRefGoogle Scholar
  12. 12.
    Ito K, Lim S, Caramori G, Cosio B, Chung KF, Adcock IM, Barnes PJ. A molecular mechanism of action of theophylline: induction of histone deacetylase activity to decrease inflammatory gene expression. Proc Natl Acad Sci USA 2002;99(13):8921–6. Epub 2002 Jun 17.PubMedCrossRefGoogle Scholar
  13. 13.
    Creamer P. Intra-articular corticosteroid injections in osteoarthritis: do they work and if so, how? Ann Rheum Dis 1997;56:634–6.PubMedCrossRefGoogle Scholar
  14. 14.
    Klint E, Grundtman C, Engstrom M, Catrina AI, Makrygiannakis D, Klareskog L et al. Intraarticular glucocorticoid treatment reduces inflammation in synovial cell infiltrations more efficiently than in synovial blood vessels. Arthritis Rheum 2005;52(12):3880–9.CrossRefGoogle Scholar
  15. 15.
    Gray RG, Tenenbaum J, Gotlieb NL. Local corticosteroid treatment in rheumatic disorders. Semin Arthritis Rheum 1981;10:231–54.PubMedCrossRefGoogle Scholar
  16. 16.
    Meikle AW, Tyler FH. Potency and duration of action of glucocorticoids: effects of hydrocortisone, prednisone and dexamethasone on human pituitary-adrenal function. Am J Med 1978;63:200.CrossRefGoogle Scholar
  17. 17.
    Centeno LM, Moore ME. Preferred intraarticular corticosteroids and associated practice: a survey of members of the American College of Rheumatology. Arthritis Care Res 1994;7(3):151–5.PubMedCrossRefGoogle Scholar
  18. 18.
    Olin BR. Hormones. Adrenal corticosteroids. In Olin BR, ed. Facts and Comparisons. St. Louis: Wolters Kluwer; 1993:465–86.Google Scholar
  19. 19.
    Pyne D, Ioannou Y, Mootoo R, Bhanji A. Intra-articular steroid in knee osteoarthritis: a comparative study of triamcinolone hexacetonide and methylprednisolone acetate. Clin Rheumatol 2004;23(2):116–20.PubMedCrossRefGoogle Scholar
  20. 20.
    Bird HA, Ring EFJ. Therapeutic value of arthroscopy. Ann Rheum Dis 1978;37:78–9.PubMedCrossRefGoogle Scholar
  21. 21.
    Lane NE, Thompson JM. Management of osteoarthritis in the primary-care setting: an evidence-based approach to treatment. Am J Med 1997;103(6A):25S–30S.PubMedCrossRefGoogle Scholar
  22. 22.
    Bellamy N, Campbell J, Welch V, Gee TL, Bourne R, Wells GA. Intraarticular corticosteroid for treatment of osteoarthritis and the knee (Review). Cochrane Database Syst Rev 2005;2:CD005328.PubMedGoogle Scholar
  23. 23.
    Arroll B, Goodyear-Smith F. Corticosteroid injections for osteoarthritis of the knee: meta-analysis. BMJ 2004;328:86.CrossRefGoogle Scholar
  24. 24.
    Jones A, Doherty M. Intra-articular corticosteroids are effective in osteoarthritis but there are no clinical predictors of response. Ann Rheum Dis 1996;55:829–32.PubMedCrossRefGoogle Scholar
  25. 25.
    Gaffney K, Ledingham J, Perry JD. Intra-articular hexacetonide in knee osteoarthritis: ­factors influencing the clinical response. Ann Rheum Dis 1995;54:379–81.PubMedCrossRefGoogle Scholar
  26. 26.
    Dieppe PA, Sathapatayavavongs B, Jones HE, Bacon PA, Ring EFJ. Intra-articular steroids in osteoarthritis. Rheumatol Rehabil 1980;19:212–17.PubMedCrossRefGoogle Scholar
  27. 27.
    Friedman DM, Moore ME. The efficacy of intra-articular steroids in OA; a double blind study. J Rheumatol 1980;7:850–6.PubMedGoogle Scholar
  28. 28.
    Ravaud P, Moulinier L, Giraudeau B. Effects of joint lavage and steroid injection in patients with osteoarthritis of the knee: results of a multicenter, randomized controlled trial. Arthritis Rheum 1999;42(3):475–82.PubMedCrossRefGoogle Scholar
  29. 29.
    Godwin M, Dawes M. Intra-articular steroid injections for painful knees. Can Fam Physician 2004;50:241–8.PubMedGoogle Scholar
  30. 30.
    McAlindon TE, Cooper C, Kirwan JR, Dieppe PA. Determinants of disability in osteoarthritis of the knee. Ann Rheum Dis 1993;52:258–62.PubMedCrossRefGoogle Scholar
  31. 31.
    Robinson P, Keenan AM, Conaghan PG. Clinical effectiveness and dose response of image-guided intra-articular corticosteroid injection for hip osteoarthritis. J Rheumatol 2005;32(7):1305–6.Google Scholar
  32. 32.
    Flanagan J, Casale FF, Thomas TL, Desai KB. Intraarticular injection for pain relief in patients awaiting hip replacement. Ann R Coll Surg Engl 1988;70:156–7.PubMedGoogle Scholar
  33. 33.
    Qvistgaard E, Christensen R, Torp-Pedersen S, Bliddal H. Intraarticular treatment of hip osteoarthritis: a randomized trial of hyaluronic acid, corticosteroid and isotonic saline. Osteoarthr Cartil 2006;14(2):163–7.PubMedCrossRefGoogle Scholar
  34. 34.
    Kullenberg B, Runesson R, Tuvhag R, Olsson C, Resch S. Intraarticular corticosteroid injection: pain relief in osteoarthritis of the hip. J Rheumatol 2004;31(11):2265–8.PubMedGoogle Scholar
  35. 35.
    Plant MJ, Borg AA, Dziedzic K, Saklatvala J, Dawes PT. Radiographic patterns and response to corticosteroid hip injection. Ann Rheum Dis 1997;56:476–80.PubMedCrossRefGoogle Scholar
  36. 36.
    Margules KR. Fluoroscopically directed steroid instillation in the treatment of hip osteoarthritis: safety and efficacy in 510 cases. Arthritis Rheum 2001;44:2449–50.PubMedCrossRefGoogle Scholar
  37. 37.
    Leveaux VM, Quin CE. Local injections of hydrocortisone and procaine in osteoarthritis of the hip. Ann Rheum Dis 1956;15:330.PubMedCrossRefGoogle Scholar
  38. 38.
    Dieppe PA. Are intra-articular steroid injections useful for the treatment of the osteoarthritis joint? Br J Rheum 1991;30:199.CrossRefGoogle Scholar
  39. 39.
    Gray RG, Gottlieb NL. Intra-articular corticosteroids: an updated assessment. Clin Orthop Relat Res 1983;177:235–62.PubMedGoogle Scholar
  40. 40.
    Meenagh GK, Patton J, Kynes C, Wright GD A randomized controlled trial of intra-articular corticosteroid injection of the carpometacarpal joint of the thumb in osteoarthritis. Ann Rheum Dis 2004;63:1260–63.PubMedCrossRefGoogle Scholar
  41. 41.
    Joshi R. Intra-articular corticosteroid injection for first carpometacarpal osteoarthritis. J Rheumatol 2005;32(7):1305–6.PubMedGoogle Scholar
  42. 42.
    Dodge LR, Brown RL, Niebauer JJ, McCaroll HR. The treatment of mucous cysts: long term follow up in sixty two cases. J Hand Surg 1984;9A:901–4.Google Scholar
  43. 43.
    Breidahl WH, Adler RS. Ultrasound guided injection of ganglia with corticosteroids. Skeletal Radiol 1996;25(7):635–8.PubMedCrossRefGoogle Scholar
  44. 44.
    Arrol B, Goodyear- Smith F. Corticosteroid injections for painful shoulder; a metaanalysis. Br J Gen Pract 2005;55(512):224–8.Google Scholar
  45. 45.
    Slipman CW, Lipetz JS, Wakeshima Y, Jackson HB. Nonsurgical treatment of zygapophyseal joint cyst-induced radicular pain. Arch Phys Med Rehabil 2000;81(7):973–7.PubMedCrossRefGoogle Scholar
  46. 46.
    Buchbinder R, Green S, Youd JM. Corticosteroid injections for shoulder pain. Cochrane Database Syst Rev 2003;(1):CD004016.PubMedGoogle Scholar
  47. 47.
    Carrera GF, Williams AL. Current concepts in evaluation of the lumbar facet joints. Crit Rev Diagn Imaging 1984;21(2):85–104.PubMedGoogle Scholar
  48. 48.
    Helbig T, Lee CK. The lumbar facet syndrome. Spine 1988;13(1):61–4.PubMedCrossRefGoogle Scholar
  49. 49.
    Revel ME, Listrat VM, Chevalier XJ, Dougados M, N’guyen MP, Vallee C et al. Facet joint block for low back pain: identifying predictors of a good response. Arch Phys Med Rehabil 1992;73(9):824–8.PubMedGoogle Scholar
  50. 50.
    Murtagh FR. Computed tomography and fluoroscopically guided anesthesia and steroid injection and facet syndrome. Spine 1992;13:686–9.Google Scholar
  51. 51.
    Slipman CW, Bhat AL, Gilchrist RV, Issac Z, Chou L, Lenrow DA. A critical review of the evidence for the use of zygapophysial injections and radiofrequency denervation in the treatment of low back pain. Spine J 2003;3(4):310–6.PubMedCrossRefGoogle Scholar
  52. 52.
    Carette S, Marcoux S, Truchon R, Grondin C, Gagnon J, Allard Y. Controlled trial of corticosteroid injections into facet joints for chronic low back pain. [Randomized controlled trial]. N Eng J Med 1991;325(14):1002–7.CrossRefGoogle Scholar
  53. 53.
    Shih C, Lin GY, Yueh KC, Lin JJ. Lumbar zygapophyseal joint injections in patients with chronic lower back pain. J Chin Med Assoc 2005;68(2):59–64.PubMedCrossRefGoogle Scholar
  54. 54.
    Sabers SR, Ross SR, Grogg BE, Lauder TD. Procedure-based nonsurgical management of lumbar zygapophyseal joint cyst-induced radicular pain. Arch Phys Med Rehabil 2005;86(9):1767–71.PubMedCrossRefGoogle Scholar
  55. 55.
    Lutz GE, Shen TC. Fluoroscopically guided aspiration of a symptomatic lumbar zygapophyseal joint cyst: a case report. Arch Phys Med Rehabil 2004;85(12):2071–2.CrossRefGoogle Scholar
  56. 56.
    Khoury NJ, el-Khoury GY, Saltzman CL, Brandser EA. Intraarticular foot and ankle injections to identify source of pain before arthrodesis. AJR Am J Roentgenol 1996;167(3):669–73.PubMedGoogle Scholar
  57. 57.
    Tallia AF, Cardone DA. Diagnostic and therapeutic injection of the ankle and foot. Am Fam Physician 2003;68(7):1356–62.PubMedGoogle Scholar
  58. 58.
    Robinson P, Keenan AM, Conaghan PG. Clinical effectiveness and dose response of image-guided intra-articular corticosteroid injection for hip osteoarthritis. Rheumatology (Oxford) 2006 Jul 26 online.Google Scholar
  59. 59.
    Rifat SF, Moeller JL. Basics of joint injection: general techniques and tips for safe, effective use. Postgrad Med 2001;109(1):157–160, 165–166.PubMedCrossRefGoogle Scholar
  60. 60.
    Korthals-de Bos IB, Smidt N, van Tulder MW, Rutten-van Mölken MPMH, Adèr HJ, van der Windt DAWM et al. Cost effectiveness of interventions for lateral epicondylitis: results from a randomised controlled trial in primary care. Pharmocoeconomics 2004;22(3):185–95.CrossRefGoogle Scholar
  61. 61.
    Smidt N, Smidt N, Assendelft WJ, van der Windt DA, Hay EM, Buchbinder R et al. Corticosteroid injections for lateral epicondylitis: a systematic review. Pain 2002;96(1–2):23–40.PubMedCrossRefGoogle Scholar
  62. 62.
    Smidt N, van der Windt DAWM, Assendelft WJJ, Deville WLJM, Korthals-de Bos IB, Bouter LM. Corticosteroid injections, physiotherapy, or a wait-and-see policy for lateral epicondylitis: a randomized controlled trial. Lancet 2002;359(9307):657–62.PubMedCrossRefGoogle Scholar
  63. 63.
    Verhaar JA, Walenkamp GH, van Mameren H, Kester AD, van der Linden AJ. Local corticosteroid injection versus Cyriax-type physiotherapy for tennis elbow. J Bone Joint Surg Br 1996;78(1):128–32.PubMedGoogle Scholar
  64. 64.
    Korthals-de Bos IB, Smidt N, van Tulder MW, Rutten-van Mölken MPMH, Adèr HJ, van der Windt DAWM et al. Cost effectiveness of interventions for lateral epicondylitis: results from a randomised controlled trial in primary care. Pharmocoeconomics 2004;22(3):185–95.CrossRefGoogle Scholar
  65. 65.
    Stahl S, Kaufman T. The efficacy of an injection of steroids for medial epicondylitis: a prospective stud of sixty elbows. J Bone Joint Surg Am 1997;79(11):1648–52.PubMedGoogle Scholar
  66. 66.
    Stahl S, Kaufman T. Ulnar nerve injury at the elbow after steroid injection for medial epicondylitis. J Hand Surg 1997;22(1):69–70.Google Scholar
  67. 67.
    Richards RR, Regan WD. Medial epicondylitis caused by injury to the medial antebrachial cutaneous nerve: a case report. Can J Surg 1989;32(5):366–367, 369.PubMedGoogle Scholar
  68. 68.
    Marshall S. Carpal tunnel syndrome. Clin Evid 2002;(8):1060–74.PubMedGoogle Scholar
  69. 69.
    Agarwal V, Singh R, Sachdev A, Wiclaff, Shekhar S, Goel D. A prospective study of the long-term efficacy of local methyl prednisolone acetate injection in the management of mild carpal tunnel syndrome. Rheumatology 2005;44(5):647–50.PubMedCrossRefGoogle Scholar
  70. 70.
    Celiker R, Arslan S, Inanici F. Corticosteroid injection vs. nonsteroidal antiinflammatory drug and splinting in carpal tunnel syndrome. Am J Phys Med Rehabil 2002;81(3):182–6.PubMedCrossRefGoogle Scholar
  71. 71.
    O’Gradaigh D, Merry P. Corticosteroid injection for the treatment of carpal tunnel syndrome. Ann Rheum Dis 2000;59(11):918–9.PubMedCrossRefGoogle Scholar
  72. 72.
    Richie CA, Briner WW Jr. Corticosteroid injection for treatment of de Quervain’s tenosynovitis: a pooled quantitative literature evaluation. J Am Board Fam Pract 2003;16(2):102–6.PubMedCrossRefGoogle Scholar
  73. 73.
    Anderson BC, Manthey R, Brouns MC. Treatment of De Quervain’s tenosynovitis with corticosteroids. A prospective study of the response to local injection. Arthritis Rheum 1991;34(7):793–8.PubMedCrossRefGoogle Scholar
  74. 74.
    Richie CA, Briner WW Jr. Corticosteroid injection for treatment of de Quervain’s tenosynovitis: a pooled quantitative literature evaluation. J Am Board Fam Pract 2003;16(2):102–6.PubMedCrossRefGoogle Scholar
  75. 75.
    Anderson BC, Manthey R, Brouns MC Treatment of De Quervain’s tenosynovitis with corticosteroids. A prospective study of the response to local injection. Arthritis Rheum 1991;34(7):793–8.PubMedCrossRefGoogle Scholar
  76. 76.
    Witt J, Pess G, Gelberman RH. Treatment of de Quervain’s tenosynovitis. J Bone Joint Surg Am 1991;73:219–22.PubMedGoogle Scholar
  77. 77.
    Apimonbutr P, Budhraja N. Suprafibrous injection with corticosteroid in de Quervain’s disease. J Med Assoc Thai 2003;86(3):232–7.PubMedGoogle Scholar
  78. 78.
    Taras JS, Raphael JS, Pan WT, Movagharnia F, Sotereanos DG. Corticosteroid injections for trigger digits: is intrasheath injection necessary? J Hand Surg Am 1998;23(4):717–22.PubMedCrossRefGoogle Scholar
  79. 79.
    Chodoroff G, Honet JC. Cheiralgia paresthetica and linear atrophy as a complication of local steroid injection. Arch Phys Med Rehabil 1985;66(9):637–9.PubMedGoogle Scholar
  80. 80.
    Murphy D, Failla JM, Koniuch MP. Steroid versus placebo injection for trigger finger. J Hand Surg Am 1995;20(4):628–31.PubMedCrossRefGoogle Scholar
  81. 81.
    Benson LS, Ptaszek AJ. Injection versus surgery in the treatment of trigger finger. J Hand Surg Am 1997;22(1):138–44.PubMedCrossRefGoogle Scholar
  82. 82.
    Nimigan AS, Ross DC, Gan BS. Steroid injections in the management of trigger fingers. Am J Phys Med Rehabil 2006;85(1):36–43.PubMedCrossRefGoogle Scholar
  83. 83.
    Anderson B, Kaye S. Treatment of flexor tenosynovitis of the hand (“trigger finger”) with corticosteroids. A prospective study of the response to local injection. Arch Intern Med 1991;151(1):153–6.PubMedCrossRefGoogle Scholar
  84. 84.
    Nimigan AS, Ross DC, Gan BS. Steroid injections in the management of trigger fingers. Am J Phys Med Rehabil 2006;85(1):36–43.PubMedCrossRefGoogle Scholar
  85. 85.
    De Wolf AN, Mens JM. Localized corticosteroid injections for the “rigger finger”: good short-term results, but with a great likelihood of recurrence. Ned Tijdschr Geneeskd 1998;142(20):1168–9 (Dutch).PubMedGoogle Scholar
  86. 86.
    Van Ijsseldijk AL, de Wilt JH, Lameris TW, Brouwer KJ. Topical corticosteroid injection for trigger finger: good short-term results, but fairly high risk of recurrence. Ned Tijdschr Geneeskd 1998;142(20):1168–9.Google Scholar
  87. 87.
    Shbeeb MI, O’Duffy JD, Michet CJ Jr, O’Fallon WM, Matteson EL. Evaluation of glucocorticosteroid injection for the treatment of trochanteric bursitis. J Rheumatol 1996;23(12):2104–6.PubMedGoogle Scholar
  88. 88.
    Ege Rasmussen KJ, Fano N. Trochanteric bursitis: treatment by corticosteroid injection. Scand J Rheumatol 1985;14(4):417–20.PubMedCrossRefGoogle Scholar
  89. 89.
    Hofmeister E, Englehardt S. Necrotizing fasciitis as complication of injection into greater trochanteric bursa. Am J Orthop 2001;30(5):426–7.PubMedGoogle Scholar
  90. 90.
    Shrier I, Matheson GO, Kohl HW(III). Achilles tendonitis: are corticosteroid injections useful or harmful? Clin J Sport Med 1996;6(4):245–50.PubMedCrossRefGoogle Scholar
  91. 91.
    Linke E. Achilles tendon ruptures following direct cortisone injection. Hefte Unfallheilkd 1975;121:302–3 German.PubMedGoogle Scholar
  92. 92.
    Gill SS, Gelbke MK, Mattson SL, Anderson MW, Hurwitz SR. Fluoroscopically guided low-volume peritendinous corticosteroid injection for Achilles tendinopathy. A safety study. J Bone Joint Surg Am 2004;86A(4):802–6.PubMedGoogle Scholar
  93. 93.
    Crawford F, Atkins D, Edwards J. Interventions for treating plantar heel pain. Cochrane Database Syst Rev 2000;3:CD000416.PubMedGoogle Scholar
  94. 94.
    Crawford F, Thomson C. Interventions for treating plantar heel pain. Cochrane Database Syst Rev 2003;3:CD000416.PubMedGoogle Scholar
  95. 95.
    Sellman JR. Plantar fascia rupture associated with corticosteroid injection. Foot Ankle Int 1994;15(7):376–81.PubMedGoogle Scholar
  96. 96.
    Tsai WC, Hsu C-C, Chen CPC, Chen MJL, Yu T-Y, Chen Y-J. Plantar fasciitis treated with local steroid injection: comparison between sonographic and palpation guidance. J Clin Ultrasound 2006;34(1):12–16.PubMedCrossRefGoogle Scholar
  97. 97.
    Tsai WC, Wang C-L, Tang F-T, Hsu T-Z, Hsu K-H, Wong M-K. Treatment of proximal plantar fasciitis with ultrasound-guided steroid injection. Arch Phys Med Rehabil 2000;81(10):1416–21.PubMedCrossRefGoogle Scholar
  98. 98.
    Stitik TP, Foye PM, Chen B, Nadler SF. Joint and soft tissue corticosteroid injections: a practical approach. Consult Prim Care 2000;40(8):1469–75.Google Scholar
  99. 99.
    Peller JS, Bardana EJ Jr. Anaphylactoid reaction to corticosteroid: case report and review of the literature. Ann Allergy 1985;54(4):302–5.PubMedGoogle Scholar
  100. 100.
    Ijsselmuiden OE, Knegt-Junk KJ, van Wijk RG, van Joost T. Cutaneous adverse reactions after intra-articular injection of triamcinolone acetonide. Acta Derm Venereol 1995;75(1):57–8.PubMedGoogle Scholar
  101. 101.
    Mace S, Vadas P, Pruzanski W. Anaphylactic shock induced by intraarticular injection of methylprednisolone acetate. J Rheumatol 1997;24(6):1191–4.PubMedGoogle Scholar
  102. 102.
    Pollock B, Wilkinson SM, MacDonald Hull SP. Chronic urticaria associated with intra-articular methylprednisolone. Br J Dematol 2001;144(6):1228–30.CrossRefGoogle Scholar
  103. 103.
    Sener O, Caliskaner Z, Yazicioglu K, Karaayvaz M, Ozanguc N. Nonpigmenting solitary fixed drug eruption after skin testing and intra-articular injection of triamcinolone acetonide. Ann Allergy Asthma Immunol 2001;86(3):335–6.PubMedCrossRefGoogle Scholar
  104. 104.
    Preuss L. Allergic reactions to systemic glucocorticoids: a review. Ann Allergy 1985;55(6):772–5.PubMedGoogle Scholar
  105. 105.
    Millard RS, Dillingham MF. Peripheral joint injections. Phys Med Rehabil Clin North Am 1995;3:841–849.Google Scholar
  106. 106.
    Gottlieb NL, Riskin WG. Complications associated with locally injected microcrystalline corticosteroid esters. JAMA 1980;243:1547.PubMedCrossRefGoogle Scholar
  107. 107.
    George WM. Linear lymphatic hypopigmentation after intralesional corticosteroid injection: report of two cases. Cutis 1999;64(1):61–4.PubMedGoogle Scholar
  108. 108.
    Kumar P, Adolph S. Hypopigmentation along subcutaneous veins following intrakeloid triamcinolone injection: a case report and review of literature. Burns 1998;24(5):487–8.PubMedCrossRefGoogle Scholar
  109. 109.
    Canturk F, Canturk T, Avdin F, Karagoz F, Senturk N, Turanli AY. Cutaneous linear atrophy following intralesional corticosteroid injection in the treatment of tendonitis. Cutis 2004;73(3):197–8.PubMedGoogle Scholar
  110. 110.
    Corazza M, Capozzi O, Virgilit A. five cases of livedo-like dermatitis (Nicolau’s syndrome) due to bismuth salts and various other non-steroidal anti-inflammatory drugs. J Eur Acad Dermatol Venereol 2001;15(6):585–8.PubMedCrossRefGoogle Scholar
  111. 111.
    KaCherasse Ahn MF, Mistrih R, Maillard R, Maillard H, Strauss J et al. Nicolau’s syndrome after local glucocorticoid injection. Joint Bone Spine 2003;70(5):390–2.CrossRefGoogle Scholar
  112. 112.
    Wicki J, Droz M, Cirafici L, Vallotton MB. Acute adrenal crisis in a patient treated with intraarticular steroid therapy. J Rheumatol 2000;27:510–1.PubMedGoogle Scholar
  113. 113.
    Cahill BR. Atraumatic osteolysis of the distal clavicle. A review. Sports Med 1992;13:214–22.PubMedCrossRefGoogle Scholar
  114. 114.
    Kay NR, Marshall PD. A safe, reliable method of carpal tunnel injection. J Hand Surg 1992;17A:1160–1.Google Scholar
  115. 115.
    Reid DM, Eastmond C, Rennie JAN. Hypothalamic-pituitary adrenal axis suppression after repeated intra-articular steroid injections. Ann Rheum Dis 1986;45:87.PubMedCrossRefGoogle Scholar
  116. 116.
    Kumar S, Singh RJ, Reed AM, Lteif AL. Cushing’s Syndrome after intraarticular and intradermal administration of Triamcinolone Acetonide in three pediatric patients. Pediatrics 2004;113(6):1820–4.PubMedCrossRefGoogle Scholar
  117. 117.
    Robinson DE, Harrison- Hansley E, Spencer RF. Steroid pyschosis after an intra-articular steroid injection. Ann Rheum Dis 2000;59:927.PubMedCrossRefGoogle Scholar
  118. 118.
    Gray RG, Tenenbaum J, Gotlieb NL. Local corticosteroid treatment in rheumatic disorders. Semin Arthritis Rheum 1981;10:231–54.PubMedCrossRefGoogle Scholar
  119. 119.
    O’Sullivan MM, Rumfeld WR, Jones MK, Williams BD. Cushing syndrome suppression of hypothalamic–pituitaryadrenal axis after intraarticular steroid injection. Ann Rheum Dis 1985;44:561–3.PubMedCrossRefGoogle Scholar
  120. 120.
    Gray RG, Gottlieb NL. Rheumatic disorders associated with diabetes mellitus: literature review. Semin Arthritis Rheum 1976;6:19–34.PubMedCrossRefGoogle Scholar
  121. 121.
    Slotkoff AT, Clauw DJ, Nashel DJ. Effects of soft tissue corticosteroid injection on glucose control in diabetics, Arthritis Rheum 1994;37:S347.Google Scholar
  122. 122.
    Romanski B, Pawlik K, Wilewska-Klubo T. The use of triamcinolone acetonide in the treatment of severe intrinsic bronchial asthma. Allergol Immunopathol 1978;6:321–4.Google Scholar
  123. 123.
    Willey RF, Fergusson RJ, Godden DJ, Crompton GK, Grant IW. Comparison of oral ­prednisolone and intramuscular depot triamcinolone in patients with severe chronic asthma. Thorax 1984;39:340–4.PubMedCrossRefGoogle Scholar
  124. 124.
    Cunningham GR, Goldzieher JW, de la Pena A, Oliver M. The mechanism of ovulation inhibition by triamcinolone acetonide. J Clin Endocrinol Metab 1978;46:8–14.PubMedCrossRefGoogle Scholar
  125. 125.
    Mens JM, Nico De Wolf A, Berkhout BJ, Stam HJ. Disturbance of menstrual pattern after local injection with triamcinolone acetonide (letter). Ann Rheum Dis 1998;57:700.PubMedCrossRefGoogle Scholar
  126. 126.
    Jansen TL, Van Roon EN. Four cases of a secondary Cushingoid state following local triamcinolone acetonide(Kenacort) injection. Neth J Med 2002;60(3):130–2.Google Scholar
  127. 127.
    Cuchacovich M, Tchernitchin A, Gatica H, Wurgaft R, Valenzuela C, Cornejo E. Intraarticular progesterone: effects of a local treatment for rheumatoid arthritis. J Rheumatol 1988;15:561–5.PubMedGoogle Scholar
  128. 128.
    Brann DW, McDonald JK, Putnam CD, Mahesh VB. Regulation of hypothalamic gonadotropin-releasing hormone and neuropeptide Y concentrations by progesterone and corticosteroids in immature rats: correlation with luteinizing hormone and follicle-stimulating hormone release. Neuroendocrinology 1991;54:425–32.PubMedCrossRefGoogle Scholar
  129. 129.
    Berger RG, Yount WJ. Immediate “steroid flare” from intraarticular triamcinolone hexacetonide injection: case report and review of the literature. Arthritis Rheum 1990;33:1284–6.PubMedCrossRefGoogle Scholar
  130. 130.
    McCarty DJ, Hogan JM. Inflammatory reaction after intrasynovial injection of microcrystalline adrenocorticosteroid esters. Arthritis Rheum 1964;7:359.PubMedCrossRefGoogle Scholar
  131. 131.
    Kahn CB, Hollander JL, Schumacher HR. Corticosteroid crystals in synovial fluid. JAMA 1970;211:807.PubMedCrossRefGoogle Scholar
  132. 132.
    Emkey RD, Lindsay R, Lyssy J, Weisberg JS, Dempster DW, Shen V. The systemic effect of intra-articular corticosteroid on markers of bone formation and bone resorption in patients with rheumatoid arthritis. Arthritis Rheum 1996;39:277–82.PubMedCrossRefGoogle Scholar
  133. 133.
    Birrer RB. Aspiration and corticosteroid injection. Practical pointers for safe relief. Phys Sports Med 1992;20:57–71.Google Scholar
  134. 134.
    Kive P. The etiology and conservative treatment of humeral epicondylitis. Scan J Rehabil Med 1982;15:37–41.Google Scholar
  135. 135.
    Gordon GV, Schumacher HR. Electron microscopy study for depot corticosteroid crystals with clinical studies after intra-articular injection. J Rheumatol 1979;6:7–14.PubMedGoogle Scholar
  136. 136.
    Chakravarty K, Pharoah PDP, Scott DGI. A randomized controlled study of post-injection rest following intra-articular steroid therapy for knee synovitis. Br J Rheumatol 1994;33:464–8.PubMedCrossRefGoogle Scholar
  137. 137.
    Neustadt DH. Intra-articular corticosteroids and other agents: aspiration techniques. In Katz W, ed. The Diagnosis and Management of Rheumatic Diseases. Second ed. Philadelphia, PA: J.B. Lippincott; 1988:812–25.Google Scholar
  138. 138.
    Sweetnam DR, Mason RM, Murray R. Steroid arthropathy of the hip. Br Med J 160;1:1392–4.Google Scholar
  139. 139.
    Murray RO. Steroids and the skeleton. Radiology 1961;77:729–43.PubMedGoogle Scholar
  140. 140.
    Steinberg CL, Duthric RB, Piva AE. Charcot-like arthropathy following intraarticular hydrocortisone. JAMA 1962;181:851–2.PubMedGoogle Scholar
  141. 141.
    Alarcon-Segovia D, Ward LE. Marked destructive changes occurring in osteoarthritic finger joints after intraarticular injection of steroids. Arthritis Rheum 1966;9:443.PubMedCrossRefGoogle Scholar
  142. 142.
    Miller RT, Restifo RA. Steroid arthropathy. Radiology 1966; 86:652–7.PubMedGoogle Scholar
  143. 143.
    Hollander JL, Jessar RA, Brown EM. Intrasynovial corticosteroid therapy: a decade of use. Bull Rheum Dis 1961;11:239.PubMedGoogle Scholar
  144. 144.
    Mankin HJ, Conger KA. The acute effects of intraarticular hydrocortisone on articular cartilage in rabbits. J Bone Jt Surg 1966;48A:1383–8.Google Scholar
  145. 145.
    Annefeld M. The dose dependent effect of glycosaminoglycan peptide complex on ­corticosteroid-induced disordered metabolism in cartilage tissue of rats. [English] Der dosisabhangige Effekt vom Glycosaminoglycan-Peptid-Komplex auf den durch Corticosteroide gestorten Stoffwechsel in Knorpelgeweben von Ratten. [German] Zeitschrift fuer Rheumatologie 1989;48(4):188–93.Google Scholar
  146. 146.
    Robion FC, Doize B, Boure L, Marcoux M, Ionescu M, Reiner A et al. Use of synovial fluid markers of cartilage synthesis and turnover to study effects of repeated intra-articular ­administration of methylprednisolone acetate on articular cartilage in vivo. J Orthop Res 2001;19(2):250–8.PubMedCrossRefGoogle Scholar
  147. 147.
    Celeste C, Ionescu M, Robin Poole A, Laverty S. Repeated intraarticular injections of triamcinolone acetonide alter cartilage matrix metabolism measured by biomarkers in synovial fluid. J Orthop Res 2005;23(3):602–10. Epub 2004 Dec 21.PubMedCrossRefGoogle Scholar
  148. 148.
    Chandler GM, Jones DT, Wright V, Hartfall SJ. Charcot’s arthropathy following intraarticular hydrocortisone. British Med J 1959;1:952–3.CrossRefGoogle Scholar
  149. 149.
    Pelletier JP, Martel-Pelletier J. Protective effects of corticosteroids on cartilage lesions and osteophyte formation in the pond-nuki dog model of osteoarthritis. Arthritis Rheum 1989;32:181–93.PubMedCrossRefGoogle Scholar
  150. 150.
    Beary JP. Osteoarthritis. In Beary JP, Christian CL, Johanson NA, eds. Manual of Rheumatology and Outpatient Orthopedic Disorders: Diagnosis and Therapy. Boston, MA: Little, Brown and Company; 1987:187–98.Google Scholar
  151. 151.
    Raynauld JP. Safety and efficacy of long-term intra-articular steroid injections in osteoarthritis of the knee. Arthritis Rheum 2003;48(2):370–7.PubMedCrossRefGoogle Scholar
  152. 152.
    Neustadt DH. Intraarticular steroid therapy. In Moskowitz RW, Howell DS, Goldberg VM, Mankin HJ, eds. Osteoarthritis: Diagnosis and Medical/Surgical Management. Philadelphia, PA: WB Saunders; 1992:493–510.Google Scholar
  153. 153.
    Hochberg MC, Altman RD, Brandt KD, Clark BM, Dieppe PA, Griffin MR et al. Guidelines for the medical management of osteoarthritis. Arthritis Rheum 1995;38(11):1535–46.PubMedCrossRefGoogle Scholar
  154. 154.
    Mazanec DJ. Pharmacology of corticosteroids in synovial joints. Phys Med Rehabil Clin North Am 1995;6:815–21.Google Scholar
  155. 155.
    Rodnan GP, Schumacher HR, Zvaifler NJ, eds. Osteoarthritis. In Primer on the Rheumatic Diseases. Eighth edition. Atlanta, GA: The Arthritis Foundation; 1983:104–8.Google Scholar
  156. 156.
    Hollander JL. Intrasynovial corticosteroid therapy in arthritis. Maryland State Med J 1972;19:62–6.Google Scholar
  157. 157.
    Miller RT, Restifo RA. Steroid arthropathy. Radiology 1966;86:652–7.PubMedGoogle Scholar
  158. 158.
    Murray RO. Steroids and the skeleton. Radiology 1961;77:729–43.PubMedGoogle Scholar
  159. 159.
    McCarty DJ, Hogan JM. Inflammatory reaction after intrasynovial injection of microcrystalline adrenocorticosteroid esters. Arthritis Rheum 1964;7:359.PubMedCrossRefGoogle Scholar
  160. 160.
    Hardin JG. Controlled study of the long term effects of “total hand” injection (abstract). Arthritis Rheum 1979;22:619.Google Scholar
  161. 161.
    Balch HW, Gibson JMC, El Ghobarey AF, El-Ghobarey AF, Bain LS, Lynch MP. Repeated corticosteroid injections into knee joints. Rheumatol Rehabil 1977;16:137–40.PubMedCrossRefGoogle Scholar
  162. 162.
    Jalava S. Periarticular calcification after intra-articular traimcinolone hexacetonide. Scand J Rheumatol 1980;9:190–2.PubMedCrossRefGoogle Scholar
  163. 163.
    Owen DS Jr. Aspiration and injections of joints and soft tissues. In Kelly WN, ed. Text Book of Rheumatology. Philadelphia, PA: WB Saunders; 1981:553–67.Google Scholar
  164. 164.
    Acevedo JI, Beskin JL. Complications of plantar fascia rupture associated with corticosteroid injection. Foot Ankle Int 1998;19(2):91–7.PubMedGoogle Scholar
  165. 165.
    Acevedo JI, Beskin JL. Complications of plantar fascia rupture associated with corticosteroid injection. Foot Ankle Int 1998;19(2):91–7.PubMedGoogle Scholar
  166. 166.
    Pfenninger JL. Injections of joints and soft tissue I: general guidelines. Am Fam Physician 1991;44:1196–202.PubMedGoogle Scholar
  167. 167.
    Kasten SJ, Louis DS. Carpal tunnel syndrome: a case of median nerve injection injury and a safe and effective method for injecting the carpal tunnel. J Fam Pract 1996;43(1):79–82.PubMedGoogle Scholar
  168. 168.
    Glaser DL, Schildorn JC, Bartolozzi AR, Dennis R, Li Y, Amato TR et al. Do you know what is on the tip of your needle? The inadvertent introduction of skin in to the joint. Arthritis Rheum 2000; 43:S149.Google Scholar
  169. 169.
    Stefanich RJ. Intra-articular corticosteroids in treatment of osteoarthritis. Orthop Rev 1986;15:65–71.PubMedGoogle Scholar
  170. 170.
    Greer III RB. Into the knee with needle and steroids [editorial]. Orthop Rev 1993;22(12):1302.PubMedGoogle Scholar
  171. 171.
    Hollander JL. Intrasynovial corticosteroid therapy in arthritis. Med J 1970;19:62.Google Scholar
  172. 172.
    Gray RG, Tenenbaum J, Gotlieb NL. Local corticosteroid treatment in rheumatic disorders. Semin Arthritis Rheum 1981;10:231–54.PubMedCrossRefGoogle Scholar
  173. 173.
    Pal B, Morris J. Perceived risks of joint infection following intra-articular corticosteroid injections: a survey of rheumatologists. Clin Rheumatol 1999;18:264–5.PubMedCrossRefGoogle Scholar
  174. 174.
    Seror P, Pluvinage P, Lecoq d’Andre F, Benamour P, Attuil G. Frequency of sepsis after local corticosteroid injection (an inquiry on 1 160 000 injections in rheumatological private practice in France). Rheumatology 1999;38:1272–4.PubMedCrossRefGoogle Scholar
  175. 175.
    Frederick HA, Carter PR, Littler JW. Injection injuries to the median and ulnar nerves at the wrist. J Hand Surg (Am) 1992;17(4):645–7.CrossRefGoogle Scholar
  176. 176.
    McConnell JR, Bush DC. Intraneural steroid injection as a complication in the management of carpal tunnel syndrome. A report of three cases. Clin Orthop Relat Res 1990;(250):181–4.Google Scholar
  177. 177.
    Iizuka M, Yao R, Wainapel S. Saphenous nerve injury following medial knee joint injection: a case report. Arch phys Med Rehabil 2005;86(10):2062–5.PubMedCrossRefGoogle Scholar
  178. 178.
    Foye PM, Stitik TP. Fluoroscopic guidance during injections for osteoarthritis. Arch Phys Med Rehabil 2006;87(3):446–7.PubMedCrossRefGoogle Scholar
  179. 179.
    Green S, Buchbinder R, Glazier R, Forbes A. Systematic review of randomised controlled trials of interventions for painful shoulder; selection criteria, outcome assessment and efficacy. Br J Gen Pract 1998; 316(7128):354–60.Google Scholar
  180. 180.
    Covino BG. Pharmacology of local anaesthetic agents. Br J Anaesth 1986 Jul;58(7):701–16.PubMedCrossRefGoogle Scholar
  181. 181.
    Kieffer SA, Binet EF, Dairs DO, et al. Lumbar myelography with iohexol and metrizamide: a comparative multicenter prospective study. Invest Radiol 1986;20:522–30.Google Scholar
  182. 182.
    Obermann WR, Gerard JK. Knee Arthrography: a comparison of iohexol, ioxaglate sodium meglumine, and metrizoate1. Radiology 1987;162:729–33.PubMedGoogle Scholar
  183. 183.
    Laerum F. Acute damage to human endothelial cells by brief exposure to contrast media in vitro. Radiology 1983;147:681–4.PubMedGoogle Scholar
  184. 184.
    Hall FM, Goldberg RP, Wyshak G, Kilcoyne RF. Shoulder arthrography: a comparison of morbidity after use of various media. Radiology 1985;154:339–41.PubMedGoogle Scholar
  185. 185.
    Kaplan PA, Lieberman RP, Chu WK. Comparison of omnipaque with hypaque in temporomandibular arthrography. Am J Roentgenol 1989;153:1225–7.Google Scholar
  186. 186.
    “Omnipaque™ (iohexol) Injection 240 300 350.” Daily Med 24 May 2006. http://dailymed.nlm.nih.gov/dailymed/fdaDrugXsl.cfm?id=707&type=display 28 September 2006.
  187. 187.
    Almén T. Angiography with metrizamide. Animal experiments and preliminary clinical experiences. Acta Radiol (Suppl) 1977;355:419–30.Google Scholar
  188. 188.
    Skalpe IO. Adverse effects of water-soluble contrast media in myelography, cisternography and ventriculography. A review with special reference to metrizamide. Acta Radiol (Suppl) 1977;355:369–70.Google Scholar
  189. 189.
    Kieffer SA, Binet EF, Dairs DO et al. Lumbar myelography with iohexol and metrizamide: a comparative multicenter prospective study. Invest Radiol 1986;20:522–30.Google Scholar
  190. 190.
    Obermann WR, Gerard JK. Knee Arthrography: a comparison of iohexol, ioxaglate sodium meglumine, and metrizoate1. Radiology 1987;162:729–33.PubMedGoogle Scholar
  191. 191.
    Laerum F. Acute damage to human endothelial cells by brief exposure to contrast media in vitro. Radiology 1983;147:681–4.PubMedGoogle Scholar
  192. 192.
    Hall FM, Goldberg RP, Wyshak G, Kilcoyne RF. Shoulder arthrography: a comparison of morbidity after use of various media. Radiology 1985;154:339–41.PubMedGoogle Scholar
  193. 193.
    Kaplan PA, Lieberman RP, Chu WK. Comparison of omnipaque with hypaque in temporomandibular arthrography. Am J Roentgenol 1989;153:1225–7.Google Scholar
  194. 194.
    Almén T. Angiography with metrizamide. Animal experiments and preliminary clinical experiences. Acta Radiol (Suppl) 1977;355:419–30.Google Scholar
  195. 195.
    Skalpe IO. Adverse effects of water-soluble contrast media in myelography, cisternography and ventriculography. A review with special reference to metrizamide. Acta Radiol (Suppl) 1977;355:369–70.Google Scholar
  196. 196.
    Owen DS. Aspiration and injection of joints and soft tissues. In Kelly WN, Harris ED, Ruddy S, Sledge CB, eds. Textbook of Rheumatology. Fourth Ed. Philadelphia: PA: WB Saunders; 1993:545.Google Scholar
  197. 197.
    Caruso I, Montrone F, Fumagelli M, Patrono C, Santandrea S, Gandini MC. Rheumatoid knee synovitis successfully treated with intraarticular rifamycin SV. Ann Rheum Disease 1982;41:232–6.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Todd P. Stitik
    • 1
  • Ajay Kumar
  • Jong H. Kim
  • Jiaxin J. Tran
  • Charles Lee
  1. 1.Department of Physical Medicine and RehabilitationNew Jersey Medical SchoolNewarkUSA

Personalised recommendations